ID

38139

Description

Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis; ODM derived from: https://clinicaltrials.gov/show/NCT01923220

Link

https://clinicaltrials.gov/show/NCT01923220

Keywords

Versions (1)
  1. 9/21/19 9/21/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 21, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT01923220

English

Eligibility Breast Cancer NCT01923220

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients 18 years old and above.
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
histology confirmed unilateral breast cancer following lumpectomy
Description

Unilateral Breast Neoplasm Following Segmental Mastectomy

Data type

boolean

Alias
UMLS CUI [1,1]
C4018978
UMLS CUI [1,2]
C0332282
UMLS CUI [1,3]
C0024885
planned to receive 50 gy, whole breast xrt and regional lymph nodes radiation.
Description

X-ray beam therapy Whole breast Planned | Irradiation of lymph nodes regional Planned

Data type

boolean

Alias
UMLS CUI [1,1]
C0436209
UMLS CUI [1,2]
C0457102
UMLS CUI [1,3]
C1301732
UMLS CUI [2,1]
C2169077
UMLS CUI [2,2]
C0205147
UMLS CUI [2,3]
C1301732
ecog performance status 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
completed chemotherapy 3 weeks prior to xrt (if applicable)
Description

Chemotherapy Completed

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205197
patient should be available for the entire study period, and be able and willing to adhere to protocol requirements;
Description

Patient Available Planned Trial Duration | Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C4288390
UMLS CUI [2]
C0525058
patient must sign an informed consent form prior to undergoing any study-related procedures
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known uncontrolled diabetes
Description

Diabetic - poor control

Data type

boolean

Alias
UMLS CUI [1]
C0421258
prior radiation to breast
Description

Irradiation of breast Previous

Data type

boolean

Alias
UMLS CUI [1,1]
C2148528
UMLS CUI [1,2]
C0205156
known connective tissue disorder
Description

Connective Tissue Disease

Data type

boolean

Alias
UMLS CUI [1]
C0009782
known skin disease over the treated breast
Description

Dermatologic disorder Breast Treated

Data type

boolean

Alias
UMLS CUI [1,1]
C0037274
UMLS CUI [1,2]
C0006141
UMLS CUI [1,3]
C1522326
prior burn over treated area
Description

Burn Previous | Area Treated

Data type

boolean

Alias
UMLS CUI [1,1]
C0006434
UMLS CUI [1,2]
C0205156
UMLS CUI [2,1]
C0205146
UMLS CUI [2,2]
C1522326
evidence of infection or inflammation of breast to be treated.
Description

Communicable Disease Breast Treating | Inflammation Breast Treating

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0006141
UMLS CUI [1,3]
C1522326
UMLS CUI [2,1]
C0021368
UMLS CUI [2,2]
C0006141
UMLS CUI [2,3]
C1522326
receiving biological therapy or hormone therapy (other than herceptin) during radiation treatment/study duration and 4 weeks prior to study entry.
Description

Biological treatment | Hormone Therapy | Exception Herceptin | Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1531518
UMLS CUI [2]
C0279025
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0338204
UMLS CUI [4]
C1522449
pre-existing skin breakdown within the planned radiotherapy field at the time of study entry.
Description

Broken skin Radiation Field Planned

Data type

boolean

Alias
UMLS CUI [1,1]
C0150077
UMLS CUI [1,2]
C1882536
UMLS CUI [1,3]
C1301732
pregnancy, planned pregnancy, lactation or inadequate contraception as judged by the investigator.
Description

Pregnancy | Pregnancy, Planned | Breast Feeding | Contraceptive methods Inadequate

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
UMLS CUI [3]
C0006147
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0205412
participation in another investigational drug or vaccine trial concurrently or within 30 days.
Description

Study Subject Participation Status | Clinical Trial Investigational New Drugs | Clinical Trial Vaccines

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0008976
UMLS CUI [2,2]
C0013230
UMLS CUI [3,1]
C0008976
UMLS CUI [3,2]
C0042210
use of any other topical or systemic treatments aimed at radiation dermatitis.
Description

Topical Administration of treatment Radiodermatitis | Systemic therapy Radiodermatitis

Data type

boolean

Alias
UMLS CUI [1,1]
C0001566
UMLS CUI [1,2]
C0034561
UMLS CUI [2,1]
C1515119
UMLS CUI [2,2]
C0034561
use of a prescription or over-the-counter medication that contains hydrocortisone or any other cortisone or corticosteroid containing preparation
Description

Hydrocortisone | Hydrocortisone Non-Prescription Drugs | Pharmaceutical Preparations Containing Cortisone | Pharmaceutical Preparations Containing Adrenal Cortex Hormones

Data type

boolean

Alias
UMLS CUI [1]
C0020268
UMLS CUI [2,1]
C0020268
UMLS CUI [2,2]
C0013231
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0332256
UMLS CUI [3,3]
C0010137
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C0332256
UMLS CUI [4,3]
C0001617
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT01923220

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female patients 18 years old and above.
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Unilateral Breast Neoplasm Following Segmental Mastectomy
Item
histology confirmed unilateral breast cancer following lumpectomy
boolean
C4018978 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C0024885 (UMLS CUI [1,3])
X-ray beam therapy Whole breast Planned | Irradiation of lymph nodes regional Planned
Item
planned to receive 50 gy, whole breast xrt and regional lymph nodes radiation.
boolean
C0436209 (UMLS CUI [1,1])
C0457102 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C2169077 (UMLS CUI [2,1])
C0205147 (UMLS CUI [2,2])
C1301732 (UMLS CUI [2,3])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Chemotherapy Completed
Item
completed chemotherapy 3 weeks prior to xrt (if applicable)
boolean
C0392920 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
Patient Available Planned Trial Duration | Protocol Compliance
Item
patient should be available for the entire study period, and be able and willing to adhere to protocol requirements;
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C4288390 (UMLS CUI [1,3])
C0525058 (UMLS CUI [2])
Informed Consent
Item
patient must sign an informed consent form prior to undergoing any study-related procedures
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Diabetic - poor control
Item
known uncontrolled diabetes
boolean
C0421258 (UMLS CUI [1])
Irradiation of breast Previous
Item
prior radiation to breast
boolean
C2148528 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Connective Tissue Disease
Item
known connective tissue disorder
boolean
C0009782 (UMLS CUI [1])
Dermatologic disorder Breast Treated
Item
known skin disease over the treated breast
boolean
C0037274 (UMLS CUI [1,1])
C0006141 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
Burn Previous | Area Treated
Item
prior burn over treated area
boolean
C0006434 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0205146 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
Communicable Disease Breast Treating | Inflammation Breast Treating
Item
evidence of infection or inflammation of breast to be treated.
boolean
C0009450 (UMLS CUI [1,1])
C0006141 (UMLS CUI [1,2])
C1522326 (UMLS CUI [1,3])
C0021368 (UMLS CUI [2,1])
C0006141 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
Biological treatment | Hormone Therapy | Exception Herceptin | Therapeutic radiology procedure
Item
receiving biological therapy or hormone therapy (other than herceptin) during radiation treatment/study duration and 4 weeks prior to study entry.
boolean
C1531518 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0338204 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4])
Broken skin Radiation Field Planned
Item
pre-existing skin breakdown within the planned radiotherapy field at the time of study entry.
boolean
C0150077 (UMLS CUI [1,1])
C1882536 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned | Breast Feeding | Contraceptive methods Inadequate
Item
pregnancy, planned pregnancy, lactation or inadequate contraception as judged by the investigator.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
C0006147 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0205412 (UMLS CUI [4,2])
Study Subject Participation Status | Clinical Trial Investigational New Drugs | Clinical Trial Vaccines
Item
participation in another investigational drug or vaccine trial concurrently or within 30 days.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0008976 (UMLS CUI [3,1])
C0042210 (UMLS CUI [3,2])
Topical Administration of treatment Radiodermatitis | Systemic therapy Radiodermatitis
Item
use of any other topical or systemic treatments aimed at radiation dermatitis.
boolean
C0001566 (UMLS CUI [1,1])
C0034561 (UMLS CUI [1,2])
C1515119 (UMLS CUI [2,1])
C0034561 (UMLS CUI [2,2])
Hydrocortisone | Hydrocortisone Non-Prescription Drugs | Pharmaceutical Preparations Containing Cortisone | Pharmaceutical Preparations Containing Adrenal Cortex Hormones
Item
use of a prescription or over-the-counter medication that contains hydrocortisone or any other cortisone or corticosteroid containing preparation
boolean
C0020268 (UMLS CUI [1])
C0020268 (UMLS CUI [2,1])
C0013231 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C0010137 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C0332256 (UMLS CUI [4,2])
C0001617 (UMLS CUI [4,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial